http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2446763-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5a40bb5481ffec2078f385fcb9d14c3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate | 2002-05-07^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_444f02eb5b05537e3f6863e52c096aec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e76ba6b7fd5c1a8abd441e110464aa47 |
| publicationDate | 2002-11-21^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2446763-A1 |
| titleOfInvention | Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof |
| abstract | The present invention relates to new compounds of formula (I): in which: R1, R2 and R3, identical or different, each represents independently: - a (C1-C6) alkyl group, - a pyridinyl group, or - a group -CH2-NR4R5 in which R4 and R5 each independently represent a hydrogen atom, a (C1-C4) alkyl group or else R4 and R5 form with the nitrogen atom to which they are linked, a pyrrolidinyl, piperidinyl group, hexahydroazepinyl, morpholinyl or piperazinyl, provided that one at less of the substituents R1, R2 or R3 is different from the group (C1-C6) alkyl, and their salts, solvates and hydrates, in particular pharmaceutically acceptable. These compounds are useful in particular for the treatment of venous circulation disorders. |
| priorityDate | 2001-05-11^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 71 of 71.